BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17895108)

  • 1. Vasodilator responses to acetazolamide tested in subtypes of vascular dementia.
    Meyer JS; Konno S; Margishvili GM; Terayama Y
    J Stroke Cerebrovasc Dis; 1998; 7(5):323-9. PubMed ID: 17895108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular dementia: still a debatable entity?
    Loeb C; Meyer JS
    J Neurol Sci; 1996 Nov; 143(1-2):31-40. PubMed ID: 8981295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification, diagnosis and treatment of vascular dementia.
    Konno S; Meyer JS; Terayama Y; Margishvili GM; Mortel KF
    Drugs Aging; 1997 Nov; 11(5):361-73. PubMed ID: 9359023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging for differentiating vascular from Alzheimer's dementias.
    Meyer JS; Shirai T; Akiyama H
    Cerebrovasc Brain Metab Rev; 1996; 8(1):1-10. PubMed ID: 9052979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective CT confirms differences between vascular and Alzheimer's dementia.
    Meyer JS; Muramatsu K; Mortel KF; Obara K; Shirai T
    Stroke; 1995 May; 26(5):735-42. PubMed ID: 7740559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?
    Erkinjuntti T; Inzitari D; Pantoni L; Wallin A; Scheltens P; Rockwood K; Desmond DW
    Ann N Y Acad Sci; 2000 Apr; 903():262-72. PubMed ID: 10818515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease.
    Kalaria RN
    Acta Neuropathol; 2016 May; 131(5):659-85. PubMed ID: 27062261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy.
    Lacombe P; Oligo C; Domenga V; Tournier-Lasserve E; Joutel A
    Stroke; 2005 May; 36(5):1053-8. PubMed ID: 15817893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformed migraine is a cause of chronic daily headaches.
    Konno S; Meyer JS; Margishvili GM; Rauch RA; Haque A
    Headache; 1999 Feb; 39(2):95-100. PubMed ID: 15613201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide testing of cerebral vasodilator capacity provokes "vascular" but not tension headaches.
    Shirai T; Meyer JS; Akiyama H; Mortel KF; Wills PM
    Headache; 1996; 36(10):589-94. PubMed ID: 8990598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small vessel disease and subcortical vascular dementia.
    Kalaria RN; Erkinjuntti T
    J Clin Neurol; 2006 Mar; 2(1):1-11. PubMed ID: 20396480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cerebral hemodynamics to acetazolamide using brain perfusion SPECT in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Park SA; Yang CY; Choi SS; Kim WH
    Clin Nucl Med; 2011 Feb; 36(2):158-9. PubMed ID: 21220990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular dementia today.
    Román GC
    Rev Neurol (Paris); 1999; 155 Suppl 4():S64-72. PubMed ID: 10637940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking.
    Chabriat H; Pappata S; Ostergaard L; Clark CA; Pachot-Clouard M; Vahedi K; Jobert A; Le Bihan D; Bousser MG
    Stroke; 2000 Aug; 31(8):1904-12. PubMed ID: 10926955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test.
    Vorstrup S
    Acta Neurol Scand Suppl; 1988; 114():1-48. PubMed ID: 3259361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two case reports of cerebral autosomal dominant arteriophaty with subcortical infarctions and leukoencephalopathy (CADASIL)].
    Pellicanò S; Costa A; Terra L
    Minerva Med; 2001 Oct; 92(5):381-4. PubMed ID: 11675581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcortical vascular dementia.
    Tomimoto H
    Neurosci Res; 2011 Nov; 71(3):193-9. PubMed ID: 21821070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition.
    Kobari M; Meyer JS; Ichijo M; Oravez WT
    AJNR Am J Neuroradiol; 1990; 11(2):273-81. PubMed ID: 2107711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology and pathogenesis of vascular cognitive impairment-a critical update.
    Jellinger KA
    Front Aging Neurosci; 2013; 5():17. PubMed ID: 23596414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.